As of 2026-09-24, the EV/EBITDA ratio of Dicerna Pharmaceuticals Inc (DRNA) is -22.81. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DRNA's latest enterprise value is 2,729.79 mil USD. DRNA's TTM EBITDA according to its financial statements is -119.65 mil USD. Dividing these 2 quantities gives us the above DRNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.7x - 17.1x | 16.6x |
| Forward P/E multiples | 18.6x - 20.7x | 18.8x |
| Fair Price | (27.22) - (24.79) | (25.77) |
| Upside | -171.2% - -164.9% | -167.4% |
| Date | EV/EBITDA |